In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease | Neurology
Quantification of α-synuclein in cerebrospinal fluid as a biomarker candidate: review of the literature and considerations for future studies | Biomarkers in Medicine
JCM | Free Full-Text | Blood Neurofilament Light Chain in Parkinson's Disease: Comparability between Parkinson's Progression Markers Initiative (PPMI) and Asian Cohorts | HTML
Integrated Analyses of Microbiome and Longitudinal Metabolome Data Reveal Microbial-Host Interactions on Sulfur Metabolism in Parkinson's Disease - ScienceDirect
Antibody‐based methods for the measurement of α‐synuclein concentration in human cerebrospinal fluid – method comparison and round robin study - Mollenhauer - 2019 - Journal of Neurochemistry - Wiley Online Library
Dr. Brit Mollenhauer, Paracelsus-Elena-Klinik – supported researcher | JPND
Frontiers | Contributing Factors and Evolution of Impulse Control Disorder in the Luxembourg Parkinson Cohort | Neurology
Parkinson's disease biomarkers based on α‐synuclein - Fayyad - 2019 - Journal of Neurochemistry - Wiley Online Library
Cerebrospinal α‐Synuclein Oligomers Reflect Disease Motor Severity in DeNoPa Longitudinal Cohort - Majbour - - Movement Disorders - Wiley Online Library
Systematic characterization of human gut microbiome-secreted molecules by integrated multi-omics | ISME Communications
Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases | Nature Reviews Neurology
Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase | npj Parkinson's Disease
Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's disease | Nature Genetics
A nanobody-based fluorescent reporter reveals human α-synuclein in the cell cytosol | Nature Communications
A combined miRNA–piRNA signature to detect Alzheimer's disease | Translational Psychiatry
Frontiers | LIPAD (LRRK2/Luebeck International Parkinson's Disease) Study Protocol: Deep Phenotyping of an International Genetic Cohort | Neurology
Decrease in Aβ42 predicts dopa-resistant gait progression in early Parkinson disease | Neurology
Cells | Free Full-Text | Protein Binding Partners of Dysregulated miRNAs in Parkinson's Disease Serum | HTML
Frontiers | Hoehn and Yahr Stage and Striatal Dat-SPECT Uptake Are Predictors of Parkinson's Disease Motor Progression | Neuroscience
Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders - Mollenhauer - 2016 - Journal of Neurochemistry - Wiley Online Library
Heterogeneity of prodromal Parkinson symptoms in siblings of Parkinson disease patients | npj Parkinson's Disease
JCM | Free Full-Text | Blood Neurofilament Light Chain in Parkinson's Disease: Comparability between Parkinson's Progression Markers Initiative (PPMI) and Asian Cohorts | HTML
Frontiers | Preanalytical Stability of CSF Total and Oligomeric Alpha-Synuclein | Aging Neuroscience
β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration | Nature
A Phase II study to evaluate the safety and efficacy of prasinezumab in early Parkinson's disease (PASADENA): rationale, design and baseline data | medRxiv
Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression | bioRxiv
